Literature DB >> 30074252

Development of a method for the determination of hydromorphone in plasma by LC-MS.

Sherry Cox1, Joan Bergman1, Shawna Hawkins2, Kurt Sladky2.   

Abstract

A simple high-performance liquid chromatography method for the determination of hydromorphone in small volume plasma has been developed. Following solid-phase extraction using Oasis HLB cartridges, samples were separated by reverse-phase high-performance liquid chromatography on an Atlantis T3 4.6 × 150 mm column (3.0 μm) and quantified using mass spectrometry. The mobile phase was a mixture of water with 0.1% formic acid and acetonitrile with 0.1% formic acid (91:9). The standard curve ranged from 1 to 500 ng/mL. Intra- and Inter-assay variability for hydromorphone was <10%, and the average recovery was >90%. The LLOQ was 1 ng/mL. This method was successfully applied to the analysis of hydromorphone samples at this institution. This method could be useful to those investigators dealing with small sample volumes, particularly when conducting pharmacokinetic studies that require multiple sampling from the same animal.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MS; hydromorphone; pharmacokinetics; solid-phase extraction

Mesh:

Substances:

Year:  2018        PMID: 30074252     DOI: 10.1002/bmc.4357

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  2 in total

1.  Simultaneous detection of a panel of nine sedatives and metabolites in plasma from critically ill pediatric patients via UPLC-MS/MS.

Authors:  Jonathan Birabaharan; Raymond E West; Thomas D Nolin; Chani Traube; Michael J Bell; Philip E Empey
Journal:  J Pharm Biomed Anal       Date:  2022-05-23       Impact factor: 3.571

2.  Long-Term Stability of Hydromorphone in Human Plasma Frozen at -20°C for Three Years Quantified by LC-MS/MS.

Authors:  Andreas Wehrfritz; Stefanie Schmidt; Harald Ihmsen; Jürgen Schüttler; Christian Jeleazcov
Journal:  Int J Anal Chem       Date:  2022-06-28       Impact factor: 1.698

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.